Pek 10 vial2 stokJimat 17%Tesamorelin 5 mg
Analog GHRH yang distabilkan
Tesamorelin GHRH analogue research peptide, Australian-shipped. Lab-verified ≥99% purity.
Untuk tujuan penyelidikan sahaja. Sebatian ini dijual secara ketat untuk penyelidikan in-vitro dan tujuan makmal, dan tidak dimaksudkan untuk kegunaan manusia atau penggunaan terapeutik. Dengan membeli, anda mengesahkan bahawa anda ialah penyelidik yang berkelayakan dan bersetuju dengan penafian penuh kami.
Tinggal 2 pek sahaja
Analog hormon pelepas hormon pertumbuhan yang distabilkan, dikaji untuk kesan terhadap tisu adipos viseral dan aktiviti paksi IGF-1 dalam model penyelidikan.
Tesamorelin is a stabilised analogue of growth-hormone-releasing hormone (GHRH) — modified to extend its half-life relative to native GHRH. It is one of the most studied GHRH-analogue research peptides and the only one of its class to have undergone regulatory approval in any jurisdiction (for HIV-associated lipodystrophy, in the US, under the brand name Egrifta). Quantum Labs supplies Tesamorelin as a lyophilised powder for Australian research applications.
Research on Tesamorelin has covered models of growth-hormone secretion, body composition, lipid metabolism, and IGF-1 dynamics. Material is HPLC-verified to ≥99% purity and ships from Australian stock; supplied for laboratory research use only.
Mekanisme
Dikaji untuk pengikatan terpilih pada reseptor GHRH dengan separuh hayat yang dilanjutkan. Penyelidikan dikaitkan dengan penanda lemak viseral yang berkurang dan IGF-1 yang meningkat dalam populasi kajian.
Disahkan HPLC terhadap spesifikasi ketulenan ≥99%. Diuji secara bebas oleh makmal pihak ketiga bertauliah.
Tesamorelin — soalan lazim
What is Tesamorelin?
Tesamorelin is a stabilised synthetic analogue of growth-hormone-releasing hormone (GHRH). It is studied in growth-hormone research and pre-clinical models of metabolic regulation and body composition.
Is Tesamorelin legal in Australia?
Tesamorelin is not approved as a therapeutic in Australia and remains available for research and laboratory use when supplied without therapeutic representation. Quantum Labs supplies Tesamorelin for research use only.
What is the difference between Tesamorelin and CJC-1295?
Both are GHRH-analogue research peptides. CJC-1295 has a longer half-life and a stronger ability to extend the duration of GH pulses; Tesamorelin's modifications produce a shorter-acting but well-characterised GHRH-mimicking profile. They are studied as parallel research tools for different aspects of GHRH-pathway signalling.
What is the typical Tesamorelin research dosage?
Published clinical research (in the US, for the approved indication) has used 2 mg daily subcutaneous Tesamorelin. Research-protocol dosing varies by model. Human therapeutic dosing is not established in Australia.
Panduan berkaitan Tesamorelin
Penyelidik juga meneliti
Pilihan utamaPek 10 vialJimat 25%Retatrutide
Serbuk liofilisasi10 mg · 8 strengths
Peptida penyelidikan tri-agonis GLP-1 / GIP / glukagon
Dalam 1 gabungan
Pek 10 vialJimat 22%MOTS-c
Serbuk liofilisasi10 mg · 2 strengths
Peptida metabolik terbitan mitokondria
Dalam 2 gabungan
Pek 10 vialJimat 17%5-Amino-1MQ
Serbuk liofilisasi50 mg · 3 strengths
Sebatian penyelidikan perencat NNMT